Management of Nail Disease in Patients With Psoriatic Arthritis : An Updated Literature Review Informing the 2021 GRAPPA Treatment Recommendations

• Published in: The Journal of Rheumatology
• Main Authors: Laheru, Dhruvkumar, Antony, Anna, Carneiro, Sueli, Di Lernia, Vito, Garg, Amit, Löve, Þorvarður Jón, Del Rocio Macias Garcia, Karla, Mendonça, José Alexandre, Mukherjee, Sandeep, Olteanu, Rodica, Perez-Chada, Lourdes, Rosen, Cheryl F, Tannenbaum, Rachel, Yazbek, Michel Alexandre
• Other Authors: Faculty of Medicine, Other departments
• Format: Article in Journal/Newspaper
• Language: English
• Published: 2023
• Subjects: Gigtarlæknisfræði; Humans; Arthritis; Psoriatic/therapy; Quality of Life; Psoriasis/therapy; Nail Diseases/pathology; Adrenal Cortex Hormones; Cyclosporins; GRAPPA; psoriasis; psoriatic arthritis; Rheumatology; Immunology and Allergy; Immunology; Brigham; Canada; Perez; Iceland
• Online Access: https://hdl.handle.net/20.500.11815/4067; https://doi.org/10.3899/jrheum.220313

Copyright © 2023 by the Journal of Rheumatology. Publisher Copyright: Copyright © 2023 by the Journal of Rheumatology. Funding Information: 1D. Laheru, MBBS, Royal Berkshire Hospitals NHS Foundation Trust, Reading, UK; 2A. Antony, MBBS, Monash University, Melbourne, Australia; 3S. Carneiro, MD, PhD, Federal University of Rio de Janeiro and State University of Rio de Janeiro, Rio de Janeiro, Brazil; 4V. Di Lernia, MD, Dermatology Unit, Arcispedale Santa Maria Nuova, Azienda USL-IRCCS di Reggio Emilia, Reggio Emilia, Italy; 5A. Garg, MD, Department of Dermatology, Donald and Barbara Zucker School of Medicine at Hofstra/ Northwell, Hempstead, New York, USA; 6T.J. Love, MD, PhD, Faculty of Medicine, University of Iceland and Landspitali University Hospital, Reykjavik, Iceland; 7K. del Rocio Macias Garcia, MD, CINEA Investigation Center, Hospital Country 2000, Guadalajara, Jalisco, Mexico; 8J.A. Mendonça, PhD, Pontifical Catholic University of Campinas, Campinas, São Paulo, Brazil; 9S. Mukherjee, MA (Med Ed), Rheumatology Department, University Hospitals Dorset NHS Foundation Trust, Dorset, UK; 10R. Olteanu, MD, PhD, Dermatology, Colentina Clinical Hospital, Bucharest, Romania; 11L. Perez-Chada, MD, MMSc, Brigham and Women’s Hospital, Harvard Medical School, Boston, Massachusetts, USA; 12C.F. Rosen, MD, Division of Dermatology, Toronto Western Hospital, University of Toronto, Toronto, Canada; 13R. Tannenbaum, MD, Northwell Health Department of Dermatology, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Hempstead, New York, USA; 14M.A. Yazbek, MD, PhD, State University of Campinas, Campinas, Brazil. DL received fees from AbbVie, Almirall, Leo Pharma, and UCB Pharma for delivering and attending educational meetings, talks, and conferences. AA is supported by an Australian Rheumatology Association-Arthritis Australia fellowship. VDL received consultant fees from AbbVie and Novartis and has been principal investigator for studies sponsored by Eli Lilly and Janssen. AG has been an advisor for AbbVie, ...